Update on rare epithelial ovarian cancers: Based on the rare ovarian tumors young investigator conference

Ji Yon Agnes Jang, Nozomu Yanaihara, Eric Pujade-Lauraine, Yoshiki Mikami, Katsutoshi Oda, Michael Bookman, Jonathan Ledermann, Muneaki Shimada, Takako Kiyokawa, Byoung Gie Kim, Noriomi Matsumura, Tsunehisa Kaku, Takafumi Kuroda, Yoko Nagayoshi, Ayako Kawabata, Yasushi Iida, Jae Weon Kim, Michael Quinn, Aikou Okamoto

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

There has been significant progress in the understanding of the pathology and molecular biology of rare ovarian cancers, which has helped both diagnosis and treatment. This paper provides an update on recent advances in the knowledge and treatment of rare ovarian cancers and identifies gaps that need to be addressed by further clinical research. The topics covered include: low-grade serous, mucinous, and clear cell carcinomas of the ovary. Given the molecular heterogeneity and the histopathological rarity of these ovarian cancers, the importance of designing adequately powered trials or finding statistically innovative ways to approach the treatment of these rare tumors has been emphasized. This paper is based on the Rare Ovarian Tumors Conference for Young Investigators which was presented in Tokyo 2015 prior to the 5th Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup (GCIG).

Original languageEnglish
Article numbere54
JournalJournal of Gynecologic Oncology
Volume28
Issue number4
DOIs
Publication statusPublished - Jan 1 2017

Fingerprint

Ovarian Neoplasms
Research Personnel
Neoplasms
Tokyo
Molecular Biology
Ovary
Pathology
Carcinoma
Ovarian epithelial cancer
Research

All Science Journal Classification (ASJC) codes

  • Oncology
  • Obstetrics and Gynaecology

Cite this

Jang, J. Y. A., Yanaihara, N., Pujade-Lauraine, E., Mikami, Y., Oda, K., Bookman, M., ... Okamoto, A. (2017). Update on rare epithelial ovarian cancers: Based on the rare ovarian tumors young investigator conference. Journal of Gynecologic Oncology, 28(4), [e54]. https://doi.org/10.3802/jgo.2017.28.e54

Update on rare epithelial ovarian cancers : Based on the rare ovarian tumors young investigator conference. / Jang, Ji Yon Agnes; Yanaihara, Nozomu; Pujade-Lauraine, Eric; Mikami, Yoshiki; Oda, Katsutoshi; Bookman, Michael; Ledermann, Jonathan; Shimada, Muneaki; Kiyokawa, Takako; Kim, Byoung Gie; Matsumura, Noriomi; Kaku, Tsunehisa; Kuroda, Takafumi; Nagayoshi, Yoko; Kawabata, Ayako; Iida, Yasushi; Kim, Jae Weon; Quinn, Michael; Okamoto, Aikou.

In: Journal of Gynecologic Oncology, Vol. 28, No. 4, e54, 01.01.2017.

Research output: Contribution to journalReview article

Jang, JYA, Yanaihara, N, Pujade-Lauraine, E, Mikami, Y, Oda, K, Bookman, M, Ledermann, J, Shimada, M, Kiyokawa, T, Kim, BG, Matsumura, N, Kaku, T, Kuroda, T, Nagayoshi, Y, Kawabata, A, Iida, Y, Kim, JW, Quinn, M & Okamoto, A 2017, 'Update on rare epithelial ovarian cancers: Based on the rare ovarian tumors young investigator conference', Journal of Gynecologic Oncology, vol. 28, no. 4, e54. https://doi.org/10.3802/jgo.2017.28.e54
Jang, Ji Yon Agnes ; Yanaihara, Nozomu ; Pujade-Lauraine, Eric ; Mikami, Yoshiki ; Oda, Katsutoshi ; Bookman, Michael ; Ledermann, Jonathan ; Shimada, Muneaki ; Kiyokawa, Takako ; Kim, Byoung Gie ; Matsumura, Noriomi ; Kaku, Tsunehisa ; Kuroda, Takafumi ; Nagayoshi, Yoko ; Kawabata, Ayako ; Iida, Yasushi ; Kim, Jae Weon ; Quinn, Michael ; Okamoto, Aikou. / Update on rare epithelial ovarian cancers : Based on the rare ovarian tumors young investigator conference. In: Journal of Gynecologic Oncology. 2017 ; Vol. 28, No. 4.
@article{40fc67736c484a16b898f8b8f4c03234,
title = "Update on rare epithelial ovarian cancers: Based on the rare ovarian tumors young investigator conference",
abstract = "There has been significant progress in the understanding of the pathology and molecular biology of rare ovarian cancers, which has helped both diagnosis and treatment. This paper provides an update on recent advances in the knowledge and treatment of rare ovarian cancers and identifies gaps that need to be addressed by further clinical research. The topics covered include: low-grade serous, mucinous, and clear cell carcinomas of the ovary. Given the molecular heterogeneity and the histopathological rarity of these ovarian cancers, the importance of designing adequately powered trials or finding statistically innovative ways to approach the treatment of these rare tumors has been emphasized. This paper is based on the Rare Ovarian Tumors Conference for Young Investigators which was presented in Tokyo 2015 prior to the 5th Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup (GCIG).",
author = "Jang, {Ji Yon Agnes} and Nozomu Yanaihara and Eric Pujade-Lauraine and Yoshiki Mikami and Katsutoshi Oda and Michael Bookman and Jonathan Ledermann and Muneaki Shimada and Takako Kiyokawa and Kim, {Byoung Gie} and Noriomi Matsumura and Tsunehisa Kaku and Takafumi Kuroda and Yoko Nagayoshi and Ayako Kawabata and Yasushi Iida and Kim, {Jae Weon} and Michael Quinn and Aikou Okamoto",
year = "2017",
month = "1",
day = "1",
doi = "10.3802/jgo.2017.28.e54",
language = "English",
volume = "28",
journal = "Journal of Gynecologic Oncology",
issn = "2005-0380",
publisher = "Korean Society of Gynecologic Oncology and Colposcopy",
number = "4",

}

TY - JOUR

T1 - Update on rare epithelial ovarian cancers

T2 - Based on the rare ovarian tumors young investigator conference

AU - Jang, Ji Yon Agnes

AU - Yanaihara, Nozomu

AU - Pujade-Lauraine, Eric

AU - Mikami, Yoshiki

AU - Oda, Katsutoshi

AU - Bookman, Michael

AU - Ledermann, Jonathan

AU - Shimada, Muneaki

AU - Kiyokawa, Takako

AU - Kim, Byoung Gie

AU - Matsumura, Noriomi

AU - Kaku, Tsunehisa

AU - Kuroda, Takafumi

AU - Nagayoshi, Yoko

AU - Kawabata, Ayako

AU - Iida, Yasushi

AU - Kim, Jae Weon

AU - Quinn, Michael

AU - Okamoto, Aikou

PY - 2017/1/1

Y1 - 2017/1/1

N2 - There has been significant progress in the understanding of the pathology and molecular biology of rare ovarian cancers, which has helped both diagnosis and treatment. This paper provides an update on recent advances in the knowledge and treatment of rare ovarian cancers and identifies gaps that need to be addressed by further clinical research. The topics covered include: low-grade serous, mucinous, and clear cell carcinomas of the ovary. Given the molecular heterogeneity and the histopathological rarity of these ovarian cancers, the importance of designing adequately powered trials or finding statistically innovative ways to approach the treatment of these rare tumors has been emphasized. This paper is based on the Rare Ovarian Tumors Conference for Young Investigators which was presented in Tokyo 2015 prior to the 5th Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup (GCIG).

AB - There has been significant progress in the understanding of the pathology and molecular biology of rare ovarian cancers, which has helped both diagnosis and treatment. This paper provides an update on recent advances in the knowledge and treatment of rare ovarian cancers and identifies gaps that need to be addressed by further clinical research. The topics covered include: low-grade serous, mucinous, and clear cell carcinomas of the ovary. Given the molecular heterogeneity and the histopathological rarity of these ovarian cancers, the importance of designing adequately powered trials or finding statistically innovative ways to approach the treatment of these rare tumors has been emphasized. This paper is based on the Rare Ovarian Tumors Conference for Young Investigators which was presented in Tokyo 2015 prior to the 5th Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup (GCIG).

UR - http://www.scopus.com/inward/record.url?scp=85020634557&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020634557&partnerID=8YFLogxK

U2 - 10.3802/jgo.2017.28.e54

DO - 10.3802/jgo.2017.28.e54

M3 - Review article

C2 - 28541641

AN - SCOPUS:85020634557

VL - 28

JO - Journal of Gynecologic Oncology

JF - Journal of Gynecologic Oncology

SN - 2005-0380

IS - 4

M1 - e54

ER -